Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995
- 1 January 1988
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 155 (1), 29-35
- https://doi.org/10.1016/s0002-9610(88)80254-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Growth factors and intestinal neoplasmsThe American Journal of Surgery, 1988
- Gastrointestinal hormones and gastrointestinal and pancreatic carcinomasGastroenterology, 1986
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Combined effect of chronic bombesin and secretin or cholecystokinin on the rat pancreasPeptides, 1985
- Long-Term Treatment of a VIPoma With Somatostatin Analogue Resulting in Remission of Symptoms and Possible Shrinkage of MetastasesGastroenterology, 1985
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effects of chronic administration of somatostatin on rat exocrine pancreasRegulatory Peptides, 1982
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896